Trade Moderna Inc ^MRNA

MGX DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX | Morningstar

DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024 | Morningstar

Banco Santander S.A. Acquires Shares of 53,115 Moderna, Inc. (NASDAQ:MRNA)

Jefferies says market nears short term “peak RFK negativity", Vaccine makers up By Investing.com

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX | Morningstar

FY2025 EPS Estimates for Moderna Cut by Leerink Partnrs

Jefferies holds Moderna at $50 target, cites RFK concerns By Investing.com

Moderna (NASDAQ:MRNA) Stock Price Down 5% – What’s Next?

Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?

MGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ...

Shareholders that lost money on Metagenomi, Inc. (MGX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More | Morningstar

MGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In MGX To Contact Him Directly To Discuss Their Options | Morningstar

Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by John G Ullman & Associates Inc.

Fall Vaccine Updates From the Advisory Committee on Immunization Practices: New Recommendations | MDedge

FY2025 EPS Estimates for Moderna Decreased by Analyst

Analyzing Aligos Therapeutics (NASDAQ:ALGS) and Moderna (NASDAQ:MRNA)

Moderna (NASDAQ:MRNA) Shares Down 5% – Time to Sell?

Berenberg Bank Initiates Coverage on Moderna (NASDAQ:MRNA)

Hsbc Global Res Upgrades Moderna (NASDAQ:MRNA) to Strong-Buy

Berenberg sees challenges for Moderna stock—downgrades and visibility issues persist By Investing.com

Moderna (NASDAQ:MRNA) Sees Strong Trading Volume - Here's What Happened

Moderna (NASDAQ:MRNA) Receives "Overweight" Rating from Piper Sandler

Moderna (NASDAQ:MRNA) Raised to Buy at HSBC | MarketBeat

Piper Sandler sees growth potential for Moderna stock despite near-term pressures By Investing.com

KBC Group NV Sells 56,297 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential By Investing.com

Moderna, Inc. (NASDAQ:MRNA) Receives $90.22 Consensus PT from Analysts

Political Shifts: The Pulse of Pharma Stock Volatility

pfizer stocks: Pfizer and Moderna stocks drop after RFK Jr.'s nomination for Health Secretary: impact on the Pharma Industry - The Economic Times

Moderna shares surge after vaccine maker posts unexpected third-quarter profit By Investing.com

Asian Market Update: Hang Seng Index Falls on Baidu Slumps

Stock Market Today: Dow and S&P 500 Post Gains Ahead of Nvidia Earnings

Super Micro Stock Surges on Decision to Maintain Nasdaq Listing

Silver Thursday & the Hunt Brothers: History Repeating?

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Nasdaq futures decline, Nvidia shares dip following the earnings report

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024